Extent Research Assistant ×
📩 [email protected] | 📞 +1 (212) 951-1369

Request Sample/Pricing Details:

💬
Extent Research Global AI Drug Development Market
REPORT DETAILS FREE ANALYSIS INQUIRY FOR BUYING REQUEST SAMPLE
REPORT DETAILS FREE ANALYSIS INQUIRY FOR BUYING REQUEST SAMPLE

Global AI Drug Development Market

Published Date : Aug-2021
Report ID : ER- 17808
Format : PDF | XLS | PPT
Pages : 171+
Author : Julie
Reviewed By : Coralia Joe
Publisher : Extent Research
Category : Service & Software

Extent Research has lately published a report titled global AI Drug Development market. The research report covers the factors associated with development opportunities that exist across the world. The research report speaks about the historical and future data procured using research tools and primary or secondary resources. The AI Drug Development market is expected to reach the targeted market size and volume during the forecast timeframe. Furthermore, all the market strategies, drivers, distribution channel, competitive players, and demographic data offer the necessary knowledge linked to market growth and control. The report is expected to provide vital perception about the fate of the market through the market study.

Data provided by Extent Research. Source: https://www.extentresearch.com/ai-drug-development-market

In addition to the market overview, the report also incorporates the key market players Insilico Medicine, Cyclica, XtalPi Inc., Exscientia Limited, AiCure, LLC, Atomwise, Biovista Inc., Breg，Inc., Numerate, Cloud Pharmaceuticals, IBM, NuMedii, BenevolentAI, Lam Therapeutics, . The key players are projected to help give information regarding the necessary market strategies, business policies, and financial status of the market on the global platform. The regional segmentation by Product type Drug Design, Drug Synthesis, Other, , by Application Tumor, Nervous System, Other, helps better understand the business expansion strategies. There are` several sections in the report that separately sheds light on the major prospects of the global AI Drug Development market. The AI Drug Development report comprehensively helps the readers perceive the significance of the factors that shape or build the market.

Competitive Landscape

In the report, this section focuses on the crucial parameters such as the influence of key market players on the market size, share, revenue, new product launches, supply & demand chain, and market status. Right from the existing competition and the future possibilities, the report proposes all the necessary competitive factors of the global AI Drug Development market.

AI Drug Development market report provides answer for following question:

  • What is the expected growth rate of the market during the forecast period?
  • Which is the regional market assumed to grab a lion’s share?
  • What the factors expected to push the AI Drug Development market forward?
  • What are opportunities likely to trigger industrial growth in the coming years?
  • What are the challenges and threats that will have a huge impact on the AI Drug Development market growth?
  • Which are the key market players?
  • Which are the major trends that will have an impact on the market growth?

Table of Contents

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI Drug Development Market Size Growth Rate by Type, 2017 VS 2021 VS 2035
1.2.2 Drug Design
1.2.3 Drug Synthesis
1.2.4 Other
1.3 Market by Application
1.3.1 Global AI Drug Development Market Size Growth Rate by Application, 2017 VS 2021 VS 2035
1.3.2 Tumor
1.3.3 Nervous System
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global AI Drug Development Market Perspective (2017-2035)
2.2 AI Drug Development Growth Trends by Region
2.2.1 AI Drug Development Market Size by Region: 2017 VS 2021 VS 2035
2.2.2 AI Drug Development Historic Market Size by Region (2017-2022)
2.2.3 AI Drug Development Forecasted Market Size by Region (2023-2035)
2.3 AI Drug Development Market Dynamics
2.3.1 AI Drug Development Industry Trends
2.3.2 AI Drug Development Market Drivers
2.3.3 AI Drug Development Market Challenges
2.3.4 AI Drug Development Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI Drug Development Players by Revenue
3.1.1 Global Top AI Drug Development Players by Revenue (2017-2022)
3.1.2 Global AI Drug Development Revenue Market Share by Players (2017-2022)
3.2 Global AI Drug Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by AI Drug Development Revenue
3.4 Global AI Drug Development Market Concentration Ratio
3.4.1 Global AI Drug Development Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI Drug Development Revenue in 2021
3.5 AI Drug Development Key Players Head office and Area Served
3.6 Key Players AI Drug Development Product Solution and Service
3.7 Date of Enter into AI Drug Development Market
3.8 Mergers & Acquisitions, Expansion Plans
4 AI Drug Development Breakdown Data by Type
4.1 Global AI Drug Development Historic Market Size by Type (2017-2022)
4.2 Global AI Drug Development Forecasted Market Size by Type (2023-2035)
5 AI Drug Development Breakdown Data by Application
5.1 Global AI Drug Development Historic Market Size by Application (2017-2022)
5.2 Global AI Drug Development Forecasted Market Size by Application (2023-2035)
6 North America
6.1 North America AI Drug Development Market Size (2017-2035)
6.2 North America AI Drug Development Market Size by Type
6.2.1 North America AI Drug Development Market Size by Type (2017-2022)
6.2.2 North America AI Drug Development Market Size by Type (2023-2035)
6.2.3 North America AI Drug Development Market Share by Type (2017-2035)
6.3 North America AI Drug Development Market Size by Application
6.3.1 North America AI Drug Development Market Size by Application (2017-2022)
6.3.2 North America AI Drug Development Market Size by Application (2023-2035)
6.3.3 North America AI Drug Development Market Share by Application (2017-2035)
6.4 North America AI Drug Development Market Size by Country
6.4.1 North America AI Drug Development Market Size by Country (2017-2022)
6.4.2 North America AI Drug Development Market Size by Country (2023-2035)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe AI Drug Development Market Size (2017-2035)
7.2 Europe AI Drug Development Market Size by Type
7.2.1 Europe AI Drug Development Market Size by Type (2017-2022)
7.2.2 Europe AI Drug Development Market Size by Type (2023-2035)
7.2.3 Europe AI Drug Development Market Share by Type (2017-2035)
7.3 Europe AI Drug Development Market Size by Application
7.3.1 Europe AI Drug Development Market Size by Application (2017-2022)
7.3.2 Europe AI Drug Development Market Size by Application (2023-2035)
7.3.3 Europe AI Drug Development Market Share by Application (2017-2035)
7.4 Europe AI Drug Development Market Size by Country
7.4.1 Europe AI Drug Development Market Size by Country (2017-2022)
7.4.2 Europe AI Drug Development Market Size by Country (2023-2035)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI Drug Development Market Size (2017-2035)
8.2 Asia-Pacific AI Drug Development Market Size by Type
8.2.1 Asia-Pacific AI Drug Development Market Size by Type (2017-2022)
8.2.2 Asia-Pacific AI Drug Development Market Size by Type (2023-2035)
8.2.3 Asia-Pacific AI Drug Development Market Share by Type (2017-2035)
8.3 Asia-Pacific AI Drug Development Market Size by Application
8.3.1 Asia-Pacific AI Drug Development Market Size by Application (2017-2022)
8.3.2 Asia-Pacific AI Drug Development Market Size by Application (2023-2035)
8.3.3 Asia-Pacific AI Drug Development Market Share by Application (2017-2035)
8.4 Asia-Pacific AI Drug Development Market Size by Region
8.4.1 Asia-Pacific AI Drug Development Market Size by Region (2017-2022)
8.4.2 Asia-Pacific AI Drug Development Market Size by Region (2023-2035)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America AI Drug Development Market Size (2017-2035)
9.2 Latin America AI Drug Development Market Size by Type
9.2.1 Latin America AI Drug Development Market Size by Type (2017-2022)
9.2.2 Latin America AI Drug Development Market Size by Type (2023-2035)
9.2.3 Latin America AI Drug Development Market Share by Type (2017-2035)
9.3 Latin America AI Drug Development Market Size by Application
9.3.1 Latin America AI Drug Development Market Size by Application (2017-2022)
9.3.2 Latin America AI Drug Development Market Size by Application (2023-2035)
9.3.3 Latin America AI Drug Development Market Share by Application (2017-2035)
9.4 Latin America AI Drug Development Market Size by Country
9.4.1 Latin America AI Drug Development Market Size by Country (2017-2022)
9.4.2 Latin America AI Drug Development Market Size by Country (2023-2035)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI Drug Development Market Size (2017-2035)
10.2 Middle East & Africa AI Drug Development Market Size by Type
10.2.1 Middle East & Africa AI Drug Development Market Size by Type (2017-2022)
10.2.2 Middle East & Africa AI Drug Development Market Size by Type (2023-2035)
10.2.3 Middle East & Africa AI Drug Development Market Share by Type (2017-2035)
10.3 Middle East & Africa AI Drug Development Market Size by Application
10.3.1 Middle East & Africa AI Drug Development Market Size by Application (2017-2022)
10.3.2 Middle East & Africa AI Drug Development Market Size by Application (2023-2035)
10.3.3 Middle East & Africa AI Drug Development Market Share by Application (2017-2035)
10.4 Middle East & Africa AI Drug Development Market Size by Country
10.4.1 Middle East & Africa AI Drug Development Market Size by Country (2017-2022)
10.4.2 Middle East & Africa AI Drug Development Market Size by Country (2023-2035)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Insilico Medicine
11.1.1 Insilico Medicine Company Details
11.1.2 Insilico Medicine Business Overview
11.1.3 Insilico Medicine AI Drug Development Introduction
11.1.4 Insilico Medicine Revenue in AI Drug Development Business (2017-2022)
11.1.5 Insilico Medicine Recent Developments
11.2 Cyclica
11.2.1 Cyclica Company Details
11.2.2 Cyclica Business Overview
11.2.3 Cyclica AI Drug Development Introduction
11.2.4 Cyclica Revenue in AI Drug Development Business (2017-2022)
11.2.5 Cyclica Recent Developments
11.3 XtalPi Inc.
11.3.1 XtalPi Inc. Company Details
11.3.2 XtalPi Inc. Business Overview
11.3.3 XtalPi Inc. AI Drug Development Introduction
11.3.4 XtalPi Inc. Revenue in AI Drug Development Business (2017-2022)
11.3.5 XtalPi Inc. Recent Developments
11.4 Exscientia Limited
11.4.1 Exscientia Limited Company Details
11.4.2 Exscientia Limited Business Overview
11.4.3 Exscientia Limited AI Drug Development Introduction
11.4.4 Exscientia Limited Revenue in AI Drug Development Business (2017-2022)
11.4.5 Exscientia Limited Recent Developments
11.5 AiCure, LLC
11.5.1 AiCure, LLC Company Details
11.5.2 AiCure, LLC Business Overview
11.5.3 AiCure, LLC AI Drug Development Introduction
11.5.4 AiCure, LLC Revenue in AI Drug Development Business (2017-2022)
11.5.5 AiCure, LLC Recent Developments
11.6 Atomwise
11.6.1 Atomwise Company Details
11.6.2 Atomwise Business Overview
11.6.3 Atomwise AI Drug Development Introduction
11.6.4 Atomwise Revenue in AI Drug Development Business (2017-2022)
11.6.5 Atomwise Recent Developments
11.7 Biovista Inc.
11.7.1 Biovista Inc. Company Details
11.7.2 Biovista Inc. Business Overview
11.7.3 Biovista Inc. AI Drug Development Introduction
11.7.4 Biovista Inc. Revenue in AI Drug Development Business (2017-2022)
11.7.5 Biovista Inc. Recent Developments
11.8 Breg，Inc.
11.8.1 Breg，Inc. Company Details
11.8.2 Breg，Inc. Business Overview
11.8.3 Breg，Inc. AI Drug Development Introduction
11.8.4 Breg，Inc. Revenue in AI Drug Development Business (2017-2022)
11.8.5 Breg，Inc. Recent Developments
11.9 Numerate
11.9.1 Numerate Company Details
11.9.2 Numerate Business Overview
11.9.3 Numerate AI Drug Development Introduction
11.9.4 Numerate Revenue in AI Drug Development Business (2017-2022)
11.9.5 Numerate Recent Developments
11.10 Cloud Pharmaceuticals
11.10.1 Cloud Pharmaceuticals Company Details
11.10.2 Cloud Pharmaceuticals Business Overview
11.10.3 Cloud Pharmaceuticals AI Drug Development Introduction
11.10.4 Cloud Pharmaceuticals Revenue in AI Drug Development Business (2017-2022)
11.10.5 Cloud Pharmaceuticals Recent Developments
11.11 IBM
11.11.1 IBM Company Details
11.11.2 IBM Business Overview
11.11.3 IBM AI Drug Development Introduction
11.11.4 IBM Revenue in AI Drug Development Business (2017-2022)
11.11.5 IBM Recent Developments
11.12 NuMedii
11.12.1 NuMedii Company Details
11.12.2 NuMedii Business Overview
11.12.3 NuMedii AI Drug Development Introduction
11.12.4 NuMedii Revenue in AI Drug Development Business (2017-2022)
11.12.5 NuMedii Recent Developments
11.13 BenevolentAI
11.13.1 BenevolentAI Company Details
11.13.2 BenevolentAI Business Overview
11.13.3 BenevolentAI AI Drug Development Introduction
11.13.4 BenevolentAI Revenue in AI Drug Development Business (2017-2022)
11.13.5 BenevolentAI Recent Developments
11.14 Lam Therapeutics
11.14.1 Lam Therapeutics Company Details
11.14.2 Lam Therapeutics Business Overview
11.14.3 Lam Therapeutics AI Drug Development Introduction
11.14.4 Lam Therapeutics Revenue in AI Drug Development Business (2017-2022)
11.14.5 Lam Therapeutics Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

Data provided by Extent Research. Source: https://www.extentresearch.com/ai-drug-development-market